Paper Review Records
全部论文审稿周期
30 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接
121
天
Thiochromen‐4‐One Derivatives as Potent Narrow‐Spectrum Antibiotics Against Moraxella
作者
Barbara Hufnagel; Philipp Schmid; Micha Becker; Johannes Lehle; Felix Anderl; Thomas Böttcher展开收起
作者单位
1. Faculty of Chemistry, Institute of Biological Chemistry Centre for Microbiology and Environmental Systems Science (CeMESS) University of Vienna Vienna Austria; 2. Vienna Doctoral School in Chemistry (DoSChem) University of Vienna Vienna Austria; 3. Vienna Doctoral School of Pharmaceutical Nutritional and Sport Sciences (VDS PhaNuSpo) University of Vienna Vienna Austria展开收起
133
天
Multidrug Machine Learning Models for Predicting Human Immunodeficiency Virus‐1 Reverse Transcriptase Inhibitor Resistance
作者
Sumeyye Yilmaz; Huseyin Tunc; Murat Sari; Serdar Durdağı展开收起
作者单位
1. Department of Mathematical Engineering Faculty of Science and Letters Istanbul Technical University İstanbul Türkiye; 2. Department of Biostatistics and Medical Informatics School of Medicine Bahçeşehir University İstanbul Türkiye; 3. Molecular Therapy Lab Department of Pharmaceutical Chemistry, School of Pharmacy Bahçeşehir University İstanbul Türkiye; 4. Lab for Innovative Drugs (LabIND) Computational Drug Design Center (HİTMER), Bahçeşehir University İstanbul Türkiye; 5. Systems Biology Lab Biruni University Scientific Research Center Biruni University İstanbul Türkiye展开收起
153
天
Artesunate Derivatives as Anticancer Agents: Hybrid Designs and Emerging Therapeutic Strategies
作者
Milica Selaković; Ljiljana Koračak; Vladimir Ajdačić; Andrea M. Nikolić; Života Selaković; Ana Andrijević; Miguel Angel Merlos Rodrigo; Igor M. Opsenica展开收起
作者单位
1. Innovative Centre of the Faculty of Chemistry in Belgrade, Ltd. Belgrade Serbia; 2. Department of Organic Chemistry Faculty of Chemistry University of Belgrade Belgrade Serbia; 3. Department of Chemistry and Biochemistry Mendel University in Brno Brno Czech Republic展开收起
184
天
Novel Mn(II) Quinaldinate Complexes With Halogenated Imidazo[1,2‐a]pyridine and Memantine: Synthesis, Spectroscopic Studies, and Selective Pro‐Apoptotic and Pro‐Oxidative Activity in Cancer Cells
作者
Tomasz Mazur; Magdalena Rydz; Barbara Machura; Kamila Środa‐Pomianek; Olga Wesołowska; Anna Palko‐Łabuz; Dariusz Bieńko展开收起
作者单位
1. Faculty of Chemistry Wroclaw University of Science and Technology Wrocław Poland; 2. Institute of Chemistry University of Silesia Katowice Poland; 3. Department of Biophysics and Neuroscience Wrocław Medical University Wrocław Poland展开收起
222
天
Multiple Chemical Class‐Based Potent VEGFR2 Inhibitors as Anticancer Therapeutics: Structure–Activity Relationship and Chemicobiological Interactions Studies
作者
Rinki Prasad Bhagat; Ajeya Samanta; Avik Maji; Abhik Paul; Sourav Mondal; Abdul Qadir; Nikki Gupta; Balaram Ghosh; Tapan Kumar Maity展开收起
作者单位
1. Synthetic and Natural Products Research Laboratory Department of Pharmaceutical Technology Jadavpur University Kolkata West Bengal India; 2. Department of Pharmaceutical Technology JIS University Kolkata West Bengal India; 3. Department of Pharmaceutical Chemistry Haldia Institute of Pharmacy Haldia West Bengal India; 4. Epigenetic Research Laboratory Department of Pharmacy Birla Institute of Technology and Science‐Pilani Hyderabad Telangana India展开收起
72
天
Metal–Organic Framework Synthesis Strategies for Efficient Encapsulation and Sustained Release of Bioactive Compounds
作者
Danna P. Vázquez‐Poxtan; Lidia E. Chiñas‐Rojas; Enrique Flores‐Andrade; Jericó Bello‐Bello; Jesús A. Arenzano‐Altaif; Marisol Castillo‐Morales; Rafael Melo‐González; José María Rivera‐Villanueva展开收起
作者单位
1. Facultad de Ciencias Químicas Universidad Veracruzana Orizaba Veracruz México; 2. SECHITI‐Colegio de Postgraduados‐Campus Córdoba Amatlán de los Reyes Veracruz México; 3. Facultad de Ingeniería Universidad Veracruzana (UV), Campus Ixtaczoquitlán Veracruz México展开收起
FAQ
ChemMedChem审稿要多久?
截至2026-11-17,CrushSCI 收录了 ChemMedChem 的 30 篇完整审稿记录。最快一篇从收稿到录用用了 38 天(Tearing Down Scientific Boundaries: Frontiers in Medicinal Chemistry 2026,2026-07-17 收稿,2026-08-24 录用),最慢一篇用了 231 天;平均 129 天,中位数 125.5 天。
Expert Matching · Case Demo
把投稿要求,转成可验证的期刊方案
说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。
